1. Home
  2. ORIC vs HRTX Comparison

ORIC vs HRTX Comparison

Compare ORIC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • HRTX
  • Stock Information
  • Founded
  • ORIC 2014
  • HRTX 1983
  • Country
  • ORIC United States
  • HRTX United States
  • Employees
  • ORIC N/A
  • HRTX N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORIC Health Care
  • HRTX Health Care
  • Exchange
  • ORIC Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • ORIC 362.9M
  • HRTX 325.0M
  • IPO Year
  • ORIC 2020
  • HRTX 1987
  • Fundamental
  • Price
  • ORIC $9.35
  • HRTX $1.98
  • Analyst Decision
  • ORIC Strong Buy
  • HRTX Strong Buy
  • Analyst Count
  • ORIC 8
  • HRTX 2
  • Target Price
  • ORIC $18.83
  • HRTX $5.00
  • AVG Volume (30 Days)
  • ORIC 2.0M
  • HRTX 1.1M
  • Earning Date
  • ORIC 08-11-2025
  • HRTX 08-05-2025
  • Dividend Yield
  • ORIC N/A
  • HRTX N/A
  • EPS Growth
  • ORIC N/A
  • HRTX N/A
  • EPS
  • ORIC N/A
  • HRTX N/A
  • Revenue
  • ORIC N/A
  • HRTX $148,518,000.00
  • Revenue This Year
  • ORIC N/A
  • HRTX $12.08
  • Revenue Next Year
  • ORIC N/A
  • HRTX $12.57
  • P/E Ratio
  • ORIC N/A
  • HRTX N/A
  • Revenue Growth
  • ORIC N/A
  • HRTX 12.43
  • 52 Week Low
  • ORIC $3.90
  • HRTX $1.04
  • 52 Week High
  • ORIC $14.67
  • HRTX $3.73
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 62.84
  • HRTX 49.25
  • Support Level
  • ORIC $8.85
  • HRTX $1.90
  • Resistance Level
  • ORIC $9.54
  • HRTX $2.07
  • Average True Range (ATR)
  • ORIC 0.74
  • HRTX 0.10
  • MACD
  • ORIC -0.07
  • HRTX 0.00
  • Stochastic Oscillator
  • ORIC 50.98
  • HRTX 32.81

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: